The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cook Jennifer E. since 2020.
This trader's CIK number is 1754371.
At the time of last reporting, Cook Jennifer E. was the Director of Bridgebio Pharma, Inc.. (stock ticker symbol BBIO).
Also see all insider trading activities at Bridgebio Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | DNLI | 0 | $0 | 1,458 | $31,682 | 0 | $0 |
| 2021 | DNLI | 0 | $0 | 0 | $0 | 3,253 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | JAZZ | 0 | $0 | 1,658 | $221,189 | 0 | $0 |
| 2022 | JAZZ | 0 | $0 | 1,509 | $230,844 | 0 | $0 |
| 2021 | JAZZ | 0 | $0 | 417 | $50,582 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | BBIO | 0 | $0 | 129,603 | $8,787,429 | 120,255 | $1,515,212 |
| 2021 | BBIO | 0 | $0 | 0 | $0 | 3,576 | $0 |
| 2020 | BBIO | 0 | $0 | 0 | $0 | 3,576 | $0 |
1. Denali Therapeutics Inc. (DNLI)
2. Jazz Pharmaceuticals Plc (JAZZ)
3. Bridgebio Pharma, Inc. (BBIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-06 | DNLI | Sale | 1,458 | 21.73 | 31,682 |
| 2021-06-01 | DNLI | Option Ex | 3,253 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-04 | JAZZ | Sale | 417 | 119.27 | 49,735 |
| 2023-08-14 | JAZZ | Sale | 1,241 | 138.16 | 171,454 |
| 2022-12-02 | JAZZ | Sale | 420 | 154.68 | 64,965 |
| 2022-08-08 | JAZZ | Sale | 1,089 | 152.32 | 165,879 |
| 2021-12-02 | JAZZ | Sale | 417 | 121.30 | 50,582 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-24 | BBIO | Option Ex | 37,167 | 12.60 | 468,304 |
| 2026-06-23 | BBIO | Sale | 2,196 | 68.57 | 150,579 |
| 2026-06-24 | BBIO | Sale | 37,167 | 70.00 | 2,601,690 |
| 2026-06-15 | BBIO | Option Ex | 83,088 | 12.60 | 1,046,908 |
| 2026-06-15 | BBIO | Sale | 90,240 | 66.88 | 6,035,160 |
| 2021-11-16 | BBIO | Option Ex | 3,576 | .00 | 0 |
| 2020-11-16 | BBIO | Option Ex | 3,576 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cook Jennifer E. (Director of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.